Manal Haddad

14 September 2018

How the “Made in China 2025” Plan is Impacting the Pharma Industry

On a global level, the pharma industry in China has garnered a lot of interest because of the vast population the country boasts of. With a population that is slowly growing older, and the spread of illnesses and diseases rising higher, various pharma industry giants from the U.K. and the U.S. are investing in China’s […]

How the “Made in China 2025” Plan is Impacting the Pharma Industry Read More »

About Feature Writer

Manal is a seasoned business professional with over 30 years of applied experience in strategic planning, management, marketing, branding, and operations working for multi-national organizations in the FMCG and pharmaceutical industries and managing world-class brands and cross-cultural teams. His dedication to continuous learning and personal development has earned him a reputation for being a knowledgeable and insightful business leader. He believes that success is achieved through collaboration, innovation, and a commitment to excellence, and he applies this philosophy to every project he undertakes. His dedication to mentorship underscores his commitment to positively influencing the world around him. His coaching and mentoring style has been described as practical, insightful, and result-oriented. Manal’s vision for the future is to continue to innovate and inspire others to achieve their full potential while maintaining a healthy work-life balance that allows him to pursue his passions outside of business. He believes keeping a healthy lifestyle is essential to achieving long-term success and happiness, personally and professionally.

Manal Haddad

14 September 2018

How the “Made in China 2025” Plan is Impacting the Pharma Industry

Recent Comments

Manal Haddad